Aflac - AFL Stock Forecast, Price & News

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on AFL shares. JPMorgan Chase & Co. lifted their price target on Aflac from $61.00 to $62.00 in a report on Monday, July 11th. Evercore ISI decreased their target price on shares of Aflac from $60.00 to $59.00 and set an "in-line" rating for the company in a research report on Wednesday, July 6th. Citigroup initiated coverage on shares of Aflac in a report on Monday, May 23rd. They set a "neutral" rating and a $60.00 price target on the stock. Piper Sandler decreased their price objective on shares of Aflac from $68.00 to $66.00 and set an "overweight" rating for the company in a report on Friday, July 8th. Finally, Morgan Stanley increased their price objective on Aflac from $66.00 to $67.00 and gave the company an "overweight" rating in a report on Wednesday. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $62.17.

Aflac Price Performance

Aflac stock opened at $63.90 on Thursday. The stock has a market cap of $40.38 billion, a price-to-earnings ratio of 9.64, a P/E/G ratio of 2.41 and a beta of 0.93. Aflac has a 12-month low of $51.28 and a 12-month high of $67.20. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.28. The business's 50-day simple moving average is $56.67 and its 200 day simple moving average is $59.92.

Aflac (NYSE:AFL - Get Rating) last announced its quarterly earnings results on Monday, August 1st. The financial services provider reported $1.55 earnings per share for the quarter, beating analysts' consensus estimates of $1.28 by $0.27. The business had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $4.79 billion. Aflac had a net margin of 20.37% and a return on equity of 12.40%. Aflac's revenue for the quarter was down 2.9% on a year-over-year basis. During the same period last year, the company posted $1.59 EPS. As a group, research analysts anticipate that Aflac will post 5.32 earnings per share for the current year.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 1st. Investors of record on Wednesday, August 24th will be given a $0.40 dividend. The ex-dividend date of this dividend is Tuesday, August 23rd. This represents a $1.60 annualized dividend and a yield of 2.50%. Aflac's dividend payout ratio is currently 24.13%.

Insider Buying and Selling at Aflac

In other news, insider Teresa L. White sold 10,000 shares of the company's stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $59.24, for a total transaction of $592,400.00. Following the completion of the transaction, the insider now directly owns 134,256 shares of the company's stock, valued at $7,953,325.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Teresa L. White sold 10,000 shares of the business's stock in a transaction on Friday, August 5th. The shares were sold at an average price of $59.24, for a total value of $592,400.00. Following the sale, the insider now owns 134,256 shares of the company's stock, valued at $7,953,325.44. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Barbara K. Rimer sold 11,026 shares of the stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $58.49, for a total transaction of $644,910.74. Following the transaction, the director now owns 33,413 shares of the company's stock, valued at approximately $1,954,326.37. The disclosure for this sale can be found here. Insiders have sold 38,272 shares of company stock valued at $2,338,959 in the last 90 days. 1.10% of the stock is currently owned by company insiders.